CSIMarket
 


Syneos Health Inc   (SYNH)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

SYNH's Revenue Growth by Quarter and Year

Syneos Health Inc 's Revenue results by quarter and year




SYNH Revenue (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - 1,373.38 1,140.02 1,212.95
III Quarter September 1,336.22 1,348.23 1,099.00 1,177.03
II Quarter June 1,360.74 1,282.61 1,013.40 1,166.83
I Quarter March 1,336.25 1,208.75 1,163.36 1,119.01
FY   4,033.21 5,212.97 4,415.78 4,675.82



SYNH Revenue third quarter 2022 Y/Y Growth Comment
Syneos Health Inc reported decrease in Revenue in the third quarter 2022 by -0.89% to $ 1,336.22 millions, from the same quarter in 2021.
The decrease in the third quarter 2022 Syneos Health Inc 's Revenue compares unfavorably to the Company's average Revenue growth of 5.49%.

Looking into third quarter 2022 results within Medical Laboratories industry 13 other companies have achieved higher Revenue growth. While Syneos Health Inc ' s Revenue decline of -0.89% ranks overall at the positon no. 1369 in the third quarter 2022.




SYNH Revenue ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - 20.47 % -6.01 % 5.89 %
III Quarter September -0.89 % 22.68 % -6.63 % 5.57 %
II Quarter June 6.09 % 26.57 % -13.15 % 8.79 %
I Quarter March 10.55 % 3.9 % 3.96 % 5.85 %
FY   - 18.05 % -5.56 % 6.51 %

Financial Statements
Syneos Health Inc 's third quarter 2022 Revenue $ 1,336.22 millions SYNH's Income Statement
Syneos Health Inc 's third quarter 2021 Revenue $ 1,348.23 millions Quarterly SYNH's Income Statement
New: More SYNH's historic Revenue Growth >>


SYNH Revenue (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - 1.87 % 3.73 % 3.05 %
III Quarter September -1.8 % 5.12 % 8.45 % 0.87 %
II Quarter June 1.83 % 6.11 % -12.89 % 4.27 %
I Quarter March -2.7 % 6.03 % -4.09 % -2.31 %
FY (Year on Year)   - 18.05 % -5.56 % 6.51 %




Revenue third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #14
Healthcare Sector #170
Overall #1369

Revenue Y/Y Growth Statistics
High Average Low
33.51 % 5.49 % -3.25 %
(Dec 31 2017)   (Jun 30 2020)
Revenue third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #14
Healthcare Sector #170
Overall #1369
Revenue Y/Y Growth Statistics
High Average Low
33.51 % 5.49 % -3.25 %
(Dec 31 2017)   (Jun 30 2020)

Revenue by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Syneos Health Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
110.24 % 6.35 % -12.89 %
(Sep 30 2017)  


SYNH's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2022 Syneos Health Inc realized decrease in Revenue sequentially by -1.8% to $ 1,336.22 millions, from $ 1,360.74 millions released in the previous quarter.

Some cyclical influence which commonly elevate III. Quarter 2022 Revenue, could not recover the III. Quarter for the Syneos Health Inc , Benjamin Olofsson, a business insider allocated in Dubai pointed out, he detected further difficulties ahead for Syneos Health Inc and wrote that average sequential Revenue growth is at 6.35% for Syneos Health Inc .

Within Medical Laboratories industry 11 other companies have achieved higher Revenue quarter on quarter growth. While Syneos Health Inc 's Revenue growth quarter on quarter, overall rank is 1214.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #12
Healthcare Sector #161
Overall #1214
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #12
Healthcare Sector #161
Overall #1214
Revenue Q/Q Growth Statistics
High Average Low
110.24 % 6.35 % -12.89 %
(Sep 30 2017)  


SYNH's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2022 Syneos Health Inc realized decrease in Revenue from the previous quarter by -1.8% to $ 1,336.22 millions, from $ 1,360.74 millions released in the previous reporting period.

Although periodic influence commonly fuel III. Quarter 2022 Revenue, it clearly was not enough to rescue Medical Laboratories's company III. Quarter 2022 achievement, Benjamin Olofsson, a business insider allocated in Dubai pointed out.

Within Medical Laboratories industry 11 other companies have achieved higher Revenue quarter on quarter growth. While Syneos Health Inc 's Revenue growth quarter on quarter, overall rank is 1214.


Syneos Health Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
Cumulative Revenue 12 Months Ending $ 5,406.60 $ 5,418.61 $ 5,340.48 $ 5,212.97 $ 4,979.61
Y / Y Revenue Growth (TTM) 8.57 % 14.55 % 19.71 % 18.05 % 10.94 %
Year on Year Revenue Growth Overall Ranking # 1045 # 518 # 1546 # 435 # 1704
Seqeuential Revenue Change (TTM) -0.22 % 1.46 % 2.45 % 4.69 % 5.27 %
Seq. Revenue Growth (TTM) Overall Ranking # 1369 # 725 # 325 # 417 # 1521




Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Sep 30 2022 period, Syneos Health Inc 's cumulative twelve months Revenue were $ 5,407 millions, company would post below average annual Revenue growth of 5.27% year on year, if the fiscal year would end at Sep 30 2022.
A slow-down in the Syneos Health Inc 's Revenue growth from the 1360.74% growth in Jun 30 2022.

In the Healthcare sector 119 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 518 to 1045.

Revenue TTM Q/Q Growth Statistics
High Average Low
33.51 %
5.49 %
-3.25 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 14
Healthcare Sector # 120
Overall # 1045

Revenue TTM Y/Y Growth Statistics
High Average Low
156.46 %
28.61 %
-5.56 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 14
Sector # 170
S&P 500 # 1369
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Sep 30 2022 period, Syneos Health Inc 's cumulative twelve months Revenue were $ 5,407 millions, company would post below average annual Revenue growth of -5.56% year on year, if the fiscal year would end at Sep 30 2022.
A slow-down in the Syneos Health Inc 's Revenue growth from the 1360.74% growth in Jun 30 2022.

In the Healthcare sector 119 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 518 to 1045.

Revenue TTM Q/Q Growth Statistics
High Average Low
33.51 %
5.49 %
-3.25 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 14
Healthcare Sector # 120
Overall # 1045

Revenue TTM Y/Y Growth Statistics
High Average Low
156.46 %
28.61 %
-5.56 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 14
Sector # 170
S&P 500 # 1369




Other Revenue Growth
Medical Laboratories Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
SYNH's Revenue Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for SYNH's Competitors
Revenue Growth for Syneos Health Inc 's Suppliers
Revenue Growth for SYNH's Customers

You may also want to know
SYNH's Annual Growth Rates SYNH's Profitability Ratios SYNH's Asset Turnover Ratio SYNH's Dividend Growth
SYNH's Roe SYNH's Valuation Ratios SYNH's Financial Strength Ratios SYNH's Dividend Payout Ratio
SYNH's Roa SYNH's Inventory Turnover Ratio SYNH's Growth Rates SYNH's Dividend Comparisons



Companies with similar Revenue decrease for the quarter ending Sep 30 2022 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2022
Owens and Minor Inc -0.19%$ -0.191 millions
National Research Corporation-0.20%$ -0.201 millions
Livanova Plc-0.24%$ -0.241 millions
Healthcare Services Group Inc -0.27%$ -0.265 millions
Catalent Inc -0.29%$ -0.293 millions
Asensus Surgical Inc -0.31%$ -0.311 millions
Liquidia Corporation-0.43%$ -0.429 millions
Integra Lifesciences Holdings Corp-0.43%$ -0.432 millions
Pediatrix Medical Group Inc -0.62%$ -0.615 millions
China Pharma Holdings Inc -0.64%$ -0.642 millions
Acadia Pharmaceuticals Inc -0.68%$ -0.682 millions
Syneos Health Inc -0.89%$ -0.891 millions
Innovage Holding Corp -1.07%$ -1.070 millions
Procyon Corp-1.20%$ -1.200 millions
Precipio inc -1.38%$ -1.380 millions
Ati Physical Therapy Inc -1.40%$ -1.397 millions
Ocular Therapeutix Inc -1.55%$ -1.547 millions
Alpine Immune Sciences Inc -1.75%$ -1.750 millions
Surgalign Holdings Inc -1.79%$ -1.786 millions
Tenet Healthcare Corp-1.90%$ -1.900 millions
Teleflex Incorporated-1.92%$ -1.923 millions
Novocure Limited-1.95%$ -1.952 millions
Dynatronics Corporation-2.01%$ -2.014 millions
Royalty Pharma Plc-2.10%$ -2.101 millions
National Healthcare Corp-2.13%$ -2.130 millions
Fonar Corporation-2.27%$ -2.271 millions
Psychemedics Corp-2.35%$ -2.353 millions
Escalon Medical Corp -2.63%$ -2.626 millions
Lifevantage Corp-2.72%$ -2.724 millions
West Pharmaceutical Services Inc -2.77%$ -2.774 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

VNOM's Profile

Stock Price

VNOM's Financials

Business Description

Fundamentals

Charts & Quotes

VNOM's News

Suppliers

VNOM's Competitors

Customers & Markets

Economic Indicators

VNOM's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071